Story · Health Tech · Medicine & Biotech
STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.
1 outlet · first reported by STAT Health Tech on
Despite all the setbacks, Boston Scientific won’t stop pushing the Watchman. The medical-device giant committed hundreds of millions to acquire the tiny heart implant more than a decade ago, and then endured a years-long debate at the Food and Drug Administration over whether to approve it. When… (STAT Health Tech)
Coverage, in order
-
STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.Despite all the setbacks, Boston Scientific won’t stop pushing the Watchman. The medical-device giant committed hundreds of millions to acquire the tiny heart implant more than a decade ago, and then endured a years-long debate at the Food and Drug Administration over whether to approve it. When…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.